NCT01541956View on ClinicalTrials.gov

Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)

PHASE4CompletedINTERVENTIONAL
Enrollment

3,091

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin

500 mg twice daily

DRUG

vildagliptin

Vildagliptin 50 mg twice daily

Trial Locations (1)

100028

Novartis Investigative Site, Beijing

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY